Product Information

STEGLUJAN 15-100 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $17.5370 per EA under NDC 00006536803. Its NADAC has been published 336 times since Jan 22, 2020.

STEGLUJAN 15-100 MG TABLET

ertugliflozin and sitagliptin
$17.5370per EA

Strength

15; 100 mg/1; mg/1

NDC

00006536803

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA209805

On Market Since

12/19/2017

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for STEGLUJAN 15-100 MG TABLET has been published 336 times since Jan 22, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$17.5370 per EA
All-time high$17.7538 (Jul 16, 2025)
All-time low$17.5337 (Nov 18, 2020)
52-week high$17.7538
52-week low$17.5370
Median price$17.6395
Average price$17.6403
Largest weekly change-0.6% (Jan 21, 2026)
Weeks tracked336
Tracking sinceJan 22, 2020

Price History

1W

0.0%

1M

0.0%

3M

-0.3%

6M

-0.9%

1Y

-1.2%

3Y

-0.5%

5Y

-0.3%

All

-0.2%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of STEGLUJAN 15-100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for STEGLUJAN 15-100 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $17.5370 per EA (NDC 00006536803), effective Jun 24, 2026.

How has the price of STEGLUJAN 15-100 MG TABLET changed over time?

Over the history we have for it, the NADAC for STEGLUJAN 15-100 MG TABLET has held within roughly two percent of its current level. It has been tracked across 336 weekly CMS publications since Jan 22, 2020.

What are the highest and lowest recorded NADAC prices for STEGLUJAN 15-100 MG TABLET?

Since Jan 22, 2020, the NADAC for STEGLUJAN 15-100 MG TABLET has ranged from a low of $17.5337 (Nov 18, 2020) to a high of $17.7538 (Jul 16, 2025), with a median of $17.6395 per EA.

Are there cheaper alternatives to STEGLUJAN 15-100 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as STEGLUJAN 15-100 MG TABLET, but none are currently priced below it.

Who manufactures STEGLUJAN 15-100 MG TABLET?

STEGLUJAN 15-100 MG TABLET (NDC 00006536803) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.